Minneapolis
89°F
eEdition
News & Politics
Sports
Food & Culture
Business
Outdoors
Opinion
Things To Do
Obituaries
More of What Matters to Minnesota
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Minnesota State Top Stocks
Markets
Minnesota Stocks
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Angiodynamics Inc
(NQ:
ANGO
)
7.170
-0.360 (-4.78%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 14, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Angiodynamics Inc
< Previous
1
2
3
4
5
Next >
Earnings Preview: AngioDynamics
July 11, 2022
AngioDynamics (NASDAQ:ANGO) is set to give its latest quarterly earnings report on Tuesday, 2022-07-12. Here's what investors need to know before the announcement. Analysts estimate that AngioDynamics...
Via
Benzinga
AngioDynamics Posts Wider Q3 Loss On Higher Costs, Reaffirms FY22 Outlook
April 07, 2022
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
April 07, 2022
Gainers IMAC Holdings (NASDAQ:IMAC) shares increased by 60.0% to $1.6 during Thursday's pre-market session. The market value of their outstanding shares is at $41.9 million.
Via
Benzinga
The Daily Biotech Pulse: Pfizer Goes Shopping, AstraZeneca Inks Bispecific Antibody Deal, Aptinyx Faces Clinical Study Setback, Erytech Jumps On Data And More
April 07, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Earnings Scheduled For April 7, 2022
April 07, 2022
Companies Reporting Before The Bell • Cazoo Gr (NYSE:CZOO) is likely to report earnings for its fourth quarter.
Via
Benzinga
AngioDynamics's Earnings: A Preview
April 06, 2022
AngioDynamics (NASDAQ:ANGO) is set to give its latest quarterly earnings report on Thursday, 2022-04-07. Here's what investors need to know before the announcement. Analysts estimate that AngioDynamics...
Via
Benzinga
AngioDynamics's Earnings Outlook
April 06, 2022
AngioDynamics (NASDAQ:ANGO) is set to give its latest quarterly earnings report on Thursday, 2022-04-07. Here's what investors need to know before the announcement. Analysts estimate that AngioDynamics...
Via
Benzinga
A Preview Of AngioDynamics's Earnings
April 06, 2022
AngioDynamics (NASDAQ:ANGO) is set to give its latest quarterly earnings report on Thursday, 2022-04-07. Here's what investors need to know before the announcement. Analysts estimate that AngioDynamics...
Via
Benzinga
The Week Ahead In Biotech (April 3-April 9): BioXcel FDA Decision, Neurology Conference Presentations Take The Spotlight
April 03, 2022
Biopharma stocks outperformed the broader market in the week ending April 2, thereby recouping the losses from the previous week. Clinical readouts and FDA decisions were among the chief catalysts that...
Via
Benzinga
4 Stocks Insiders Are Buying
January 13, 2022
When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, t...
Via
Benzinga
AngioDynamics Earnings Perspective: Return On Capital Employed
January 07, 2022
According to Benzinga Pro data, during Q1, AngioDynamics (NASDAQ:ANGO) posted sales of $76.97 million. Earnings were up 64.19%, but AngioDynamics still reported an overall loss of...
Via
Benzinga
Earnings Scheduled For January 6, 2022
January 06, 2022
Companies Reporting Before The Bell • Northern Technologies (NASDAQ:NTIC) is estimated to report quarterly earnings at $0.18 per share on revenue of $16.90 million....
Via
Benzinga
The Week Ahead In Biotech (Jan. 2-Jan. 8): Stray Clinical Readouts In Focus In Slow News Week
January 02, 2022
Biotech stocks came under selling pressure in the final week of 2021, although they carved out modest gains for the year. Here are the key catalysts that can sway biotech stocks in the unfolding week.
Via
Talk Markets
Is This Under-the-Radar Medical Devices Stock a Buy?
November 03, 2021
The medical devices company beat analyst expectations in the first quarter of its new fiscal year. Could it be a buy?
Via
The Motley Fool
51 Biggest Movers From Friday
October 18, 2021
Gainers LM Funding America, Inc. (NASDAQ: LMFA) shares jumped 38.1% to close at $4.75 on Friday after declining around 15% on Thursday. The company recently announced it...
Via
Benzinga
10 Biggest Price Target Changes For Friday
October 15, 2021
Cowen & Co. lowered the price target on Domino's Pizza, Inc. (NYSE:
Via
Benzinga
Mid-Afternoon Market Update: Gold Rises 2%; Bed Bath & Beyond Shares Slide
September 30, 2021
Toward the end of trading Thursday, the Dow traded down 0.74% to 34,136.80 while the NASDAQ rose 0.36% to 14,565.16. The S&P also fell, dropping 0.25% to 4,348.69. The U.S....
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Benzinga's Top Ratings Upgrades, Downgrades For October 15, 2021
October 15, 2021
Upgrades B of A Securities upgraded the previous rating for WEC Energy Group Inc (NYSE:
Via
Benzinga
Investors Cheer AngioDynamics' Q1 Beat, Raised FY22 Sales Outlook
September 30, 2021
AngioDynamics Inc (NASDAQ: ANGO) reported a Q1 FY22 adjusted EPS loss of $(0.02), ahead of the consensus of $(0.04). Q1 sales increased 9.6% Y/Y to $77...
Via
Benzinga
51 Biggest Movers From Yesterday
October 01, 2021
Gainers Superior Drilling Products, Inc. (NYSE: SDPI) shares rose 60.6% to close at $1.75 on Thursday after jumping over 23% on Wednesday. The company, last month, reported Q2...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
September 30, 2021
Gainers Progenity (NASDAQ:PROG) stock increased by 21.06% to $1.31 during Thursday's regular session. The current volume of 70.4 million shares is 943.37% of Progenity...
Via
Benzinga
Mid-Day Market Update: Dow Drops Over 300 Points; Virgin Galactic Shares Jump
September 30, 2021
Midway through trading Thursday, the Dow traded down 0.97% to 34,056.76 while the NASDAQ fell 0.09% to 14,499.45. The S&P also fell, dropping 0.58% to 4,334.04. The U.S. has...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
36 Stocks Moving In Thursday's Mid-Day Session
September 30, 2021
Gainers Paltalk, Inc. (NASDAQ: PALT) shares jumped 55% to $13.00. Paltalk engaged ClearThink to lead expanded investor relations program. Farmmi, Inc. (NASDAQ: FAMI) jumped 45.5...
Via
Benzinga
Angiodynamics Inc (ANGO) Q1 2022 Earnings Call Transcript
September 30, 2021
ANGO earnings call for the period ending August 31, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Mid-Morning Market Update: Markets Mixed; CarMax Profit Misses Views
September 30, 2021
Following the market opening Thursday, the Dow traded down 0.11% to 34,352.56 while the NASDAQ climbed 0.44% to 14,576.37. The S&P also rose, gaining 0.15% to 4,365.81. The U....
Via
Benzinga
Topics
Stocks
Exposures
US Equities
The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug
September 30, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 29) Acceleron Pharma Inc. (...
Via
Benzinga
Exposures
COVID-19
Earnings Scheduled For September 30, 2021
September 30, 2021
Companies Reporting Before The Bell • Antelope Enterprise Hldgs (NASDAQ:AEHL) is likely to report earnings for its first quarter. • Paychex (NASDAQ:PAYX) is...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 20, 2021
August 20, 2021
Upgrades For Investors Bancorp Inc (NASDAQ:
Via
Benzinga
After Beating Estimates, Is This Little-Known Medical Device Company a Buy?
July 18, 2021
AngioDynamics exceeded analyst expectations on revenue in Q4 2021, but does that make it worth buying?
Via
The Motley Fool
The Daily Biotech Pulse: ScPharma's Positive Data, Lilly Goes Shopping, LeMaitre Pre-Announces Q2 Revenues
July 14, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 13) Biohaven Pharmaceutical...
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.